Mckenna Weeks, OTR/L | |
9140 Belvoir Woods Pkwy, Fort Belvoir, VA 22060-2703 | |
(703) 799-1200 | |
Not Available |
Full Name | Mckenna Weeks |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 9140 Belvoir Woods Pkwy, Fort Belvoir, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003498445 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119008943 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mckenna Weeks, OTR/L 13580 Smacks Dr, Amelia Court House, VA 23002-2866 Ph: (804) 922-2338 | Mckenna Weeks, OTR/L 9140 Belvoir Woods Pkwy, Fort Belvoir, VA 22060-2703 Ph: (703) 799-1200 |
News Archive
All Canadian babies should be vaccinated against rotavirus, according to a new statement by the Canadian Paediatric Society. The CPS is also calling for public funding of the vaccine, which is not currently covered by provincial or territorial health plans.
Eating legumes at least three times a week and brown rice at least once a week was linked to a reduced risk of colon polyps by 33 percent and 40 percent respectively, according to Loma Linda University research recently published in Nutrition and Cancer.
The disease course of COVID-19 is diverse, ranging from asymptomatic to fatal respiratory failure. Scientists have been working to uncover the immunological reasons behind this heterogeneity. A recent study on B cells, published on the preprint server medRxiv in April 2020, shows that extrafollicular B cells could be a marker of severe infection in the early stages, predicting the need for earlier immunomodulatory therapy.
iTeos Therapeutics SA announced today a strategic collaboration with Pfizer Inc. pursuant to which iTeos will license to Pfizer rights to iTeos' pre-clinical compounds targeting Indoleamine 2,3-dioxygenase (IDO1) and Tryptophan 2,3-dioxygenase (TDO2). Pfizer will be responsible for the development and commercialization of IDO1 and TDO2 drug candidates.
› Verified 6 days ago
Mr. Ernest Vargas, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9501 Farrell Rd, Fort Belvoir, VA 22060 Phone: 703-805-0009 Fax: 703-805-0820 | |
Kathryn D Allen, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9501 Farrell Rd Ste Gc-11, Attn Mcxc- Credentials, Fort Belvoir, VA 22060 Phone: 703-805-0881 | |
Issac Johnson, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 9160 Belvoir Woods Pkwy, Fort Belvoir, VA 22060 Phone: 703-781-2447 | |
Brittany Vernon, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 9160 Belvoir Woods Pkwy, Fort Belvoir, VA 22060 Phone: 703-799-1333 | |
Dr. Muzna Ahmed, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5980 9th St Bldg 1259, Fort Belvoir, VA 22060 Phone: 571-231-1210 | |
Jennie Samuel, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9300 Dewitt Loop, Fort Belvoir Community Hospital, Fort Belvoir, VA 22060 Phone: 571-231-1211 |